Literature DB >> 12223387

High-spatial-resolution MR cisternography of the cerebellopontine angle in 90 seconds with a zero-fill interpolated fast recovery 3D fast asymmetric spin-echo sequence.

Tatsuya Nakamura1, Shinji Naganawa, Tokiko Koshikawa, Hiroshi Fukatsu, Yasuo Sakurai, Ikuo Aoki, Ayako Ninomiya, Takeo Ishigaki.   

Abstract

BACKGROUND AND
PURPOSE: Although the 12-minute 3D fast asymmetric spin-echo (FASE) protocol for imaging the inner ear has been satisfactory, reducing imaging time to minimize patient discomfort and maximize system throughput is desirable. We therefore evaluated the performance of a zero-fill interpolated (ZIP) fast recovery 3D FASE sequence in screening for cerebellopontine (CP) angle lesions in 90 seconds.
METHODS: Thirty consecutive patients known or suspected to have CP angle lesions underwent MR imaging at 1.5 T with use of bilateral quadrature phased-array coils designed for examination of the CP angle. Conventional 3D FASE images (4000/240/1 [TR/TE/NEX]) were obtained in 11 minutes 48 seconds with a field of view (FOV) of 16 cm, matrix of 512 x 512 x 40, section thickness of 0.8 mm, and echo train length of 80. Then, ZIP fast recovery 3D FASE images (2000/240/1) were obtained in 90 seconds by using the same FOV. Contrast-enhanced T1-weighted 3D spoiled gradient-echo (SPGR) images were obtained as the reference standard. Three radiologists evaluated the images independently. Conventional 3D FASE and ZIP fast recovery 3D FASE images were reviewed at separate sessions.
RESULTS: On 3D SPGR images, 10 tumors were detected in 10 of the 30 patients. All lesions were depicted with both 3D FASE protocols. There were no false-positive results with either 3D FASE protocol. Both protocols showed 100% sensitivity and 100% specificity for all three reviewers.
CONCLUSION: High-spatial-resolution MR cisternography with the ZIP fast recovery 3D FASE protocol in 90 seconds results in a substantial reduction (by a factor of about eight) in the time required for screening for CP angle lesions compared with the previously reported conventional 3D FASE protocol, while maintaining high sensitivity and specificity.

Entities:  

Mesh:

Year:  2002        PMID: 12223387      PMCID: PMC7976267     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  9 in total

1.  High-resolution MR cisternography of the cerebellopontine angle: 2D versus 3D fast spin-echo sequences.

Authors:  E Iwayama; S Naganawa; T Ito; H Fukatsu; M Ikeda; T Ishigaki; N Ichinose
Journal:  AJNR Am J Neuroradiol       Date:  1999-05       Impact factor: 3.825

2.  SENSE: sensitivity encoding for fast MRI.

Authors:  K P Pruessmann; M Weiger; M B Scheidegger; P Boesiger
Journal:  Magn Reson Med       Date:  1999-11       Impact factor: 4.668

3.  MR cisternography of the cerebellopontine angle: comparison of three-dimensional fast asymmetrical spin-echo and three-dimensional constructive interference in the steady-state sequences.

Authors:  S Naganawa; T Koshikawa; H Fukatsu; T Ishigaki; T Fukuta
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

4.  Fast recovery 3D fast spin-echo MR imaging of the inner ear at 3 T.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Hiroshi Fukatsu; Takeo Ishigaki; Ikuo Aoki; Ayako Ninomiya
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

5.  MR imaging of the inner ear: comparison of a three-dimensional fast spin-echo sequence with use of a dedicated quadrature-surface coil with a gadolinium-enhanced spoiled gradient-recalled sequence.

Authors:  S Naganawa; T Ito; H Fukatsu; T Ishigaki; T Nakashima; N Ichinose; Y Kassai; M Miyazaki
Journal:  Radiology       Date:  1998-09       Impact factor: 11.105

6.  A segment-interleaved motion-compensated acquisition in the steady state (SIMCAST) technique for high resolution imaging of the inner ear.

Authors:  S Kurucay; P Schmalbrock; D W Chakeres; P J Keller
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

7.  Constructive interference in steady state-3DFT MR imaging of the inner ear and cerebellopontine angle.

Authors:  J W Casselman; R Kuhweide; M Deimling; W Ampe; I Dehaene; L Meeus
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jan-Feb       Impact factor: 3.825

8.  Cochlear fossa enhancement at MR evaluation of vestibular Schwannoma: correlation with success at hearing-preservation surgery.

Authors:  F Dubrulle; O Ernst; C Vincent; F M Vaneecloo; J P Lejeune; L Lemaitre
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

9.  The role of conservative management of vestibular schwannomas.

Authors:  R M Walsh; A P Bath; M L Bance; A Keller; C H Tator; J A Rutka
Journal:  Clin Otolaryngol Allied Sci       Date:  2000-02
  9 in total
  4 in total

1.  Screening for cerebellopontine angle tumors: is a CISS sufficient?

Authors:  Einar Goebell; Thorsten Ries; Thomas Kucinski; Ullrich Grzyska; Bernd Eckert; Jens Fiehler; Britta Eickhoff; Jan Regelsberger; Christoph Koch; Herrmann Zeumer
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

2.  Flow ghost artifact in slice-encoding direction mimicking vestibular schwannoma in contrast-enhanced 3D spoiled gradient-echo sequence.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Hiroshi Fukatsu; Takeo Ishigaki; Ikuo Aoki
Journal:  Eur Radiol       Date:  2003-11-05       Impact factor: 5.315

3.  Contrast enhancement of the cochlear aqueduct in MR imaging: its frequency and clinical significance.

Authors:  T Nakamura; S Naganawa; H Fukatsu; Y Sakurai; I Aoki; A Ninomiya; T Nakashima; T Ishigaki
Journal:  Neuroradiology       Date:  2003-08-05       Impact factor: 2.804

4.  MR imaging of the internal auditory canal and inner ear at 3T: comparison between 3D driven equilibrium and 3D balanced fast field echo sequences.

Authors:  Jun Soo Byun; Hyung Jin Kim; Yoo Jeong Yim; Sung Tae Kim; Pyoung Jeon; Keon Ha Kim; Sam Soo Kim; Yong Hwan Jeon; Jiwon Lee
Journal:  Korean J Radiol       Date:  2008 May-Jun       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.